Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
CHANGE IN RATINGS
downgraded at Deutsche from Buy to Hold. Valuation call, based on a $66 price target.
reinstated at Barclays with an Equal Weight rating and $71 price target. Improving refined products pipeline, Barclays said.
rated new Neutral at Goldman. $42 price target. Company can grow faster than its peers, but already trades at a premium valuation.
Enterprise Products Partners
reinstated at Barclays with an Overweight rating and $46 price target. EPD enhanced its long-term growth visibility by lowering its costs of capital through IDR elimination, Barclays said.
initiated at Credit Suisse with an Outperform rating and $22 price target. Well positioned to become the preeminent provider of independent medical exams, Credit Suisse said.
downgraded at BofA/Merrill to Neutral from Buy as further upside is limited, Bank of America/Merrill Lynch said. $28 price target.
downgraded at Wells to Market Perform. Valuation call, as the stock is already pricing in strong 2011 growth.
downgraded at Barclays to Equal weight from Overweight on lower near-term growth outlook, Barclays said. Price target lowered to $40 from $42.
upgraded at Morgan Stanley to Overweight. $55 price target. Growth should accelerate throughout 2011.
Research in Motion
( RIMM) downgraded at Credit Agricole. RIMM was downgraded from Buy to Underperform, Credit Agricole said. Company faces multiple potential headwinds.
downgraded at Merriman to Neutral, Merriman Curhan Ford said. Company is likely to miss quarterly sales expectations.
upgraded at BofA/Merrill to Buy from Underperform on higher than expected Fresh Pork margins, Bank of America/Merrill Lynch said. Price target lifted to $21 from $16.
rated new Buy at Citigroup. $20 price target. Company can turn its margins around and disk-drive fundamentals recover.
upgraded at BofA/Merrill to Buy from Neutral no improved demand in emerging markets and ADCT acquisition, Bank of America/Merrill Lynch said. Price target increased to $40. Estimates raised through 2012.
( TIN) downgraded at BofA/Merrill to Neutral from Buy on valuation, Bank of America/Merrill Lynch said. $24 price target.
rated new Buy at Citigroup. $55 price target. Company has a cost advantage over its competitors.
Weight Watchers International
upgraded at BofA/Merrill to Buy from Underperform on revitalized business plan, higher margins, and valuation, Bank of America/Merrill Lynch said. Price target increased to $38 from $34.
This article was written by a staff member of TheStreet.